Ultimovacs ASA: Mandatory notification of trades by primary insider
Zelluna ASA (ZLNA) · publisert 2024-03-08 22:00 · vis på NewsWeb
Transaksjoner
| Person | Rolle | Type | Volum | Pris | Dato | ISIN | Handelsplass | Tolket via |
|---|---|---|---|---|---|---|---|---|
| CGS Holding AS nærstående | Company closely associated with Leiv Askvig, board member of the Issuer | disposal | 1 015 098 140 000 | 140 000 NOK | 2024-03-08 | NO0010851603 | Oslo Børs g) Additional information N/A NOTIFICATION OF TRANSACTION CARRIED OUT BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES AND RELATED PARTIES | rules |
| Helene Sundt AS nærstående | Company closely associated with Leiv Askvig, board member of the Issuer | disposal | 1 015 098 140 000 | 140 000 NOK | 2024-03-08 | NO0010851603 | Oslo Børs g) Additional information N/A NOTIFICATION OF TRANSACTION CARRIED OUT BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES AND RELATED PARTIES | rules |
| Sundt AS nærstående | Company closely associated with Leiv Askvig, board member of the Issuer | disposal | 1 015 098 140 000 | 140 000 NOK | 2024-03-08 | NO0010851603 | Oslo Børs g) Additional information N/A | rules |
Vedlegg
- 20240308 - Ultimovacs Notification of trade - PDMR form.pdf (tekst hentet ut)
Meldingstekst
Oslo, 8 March 2024: CGS Holding AS, a closely related party of Leiv Askvig, a
board member and primary insider in Ultimovacs ASA, has today sold 140,000
shares in the company at an average price of NOK 7.2507 per share. Following
these transactions, CGS Holding AS holds 0 shares in Ultimovacs ASA.
Helene Sundt AS, a closely related party of Leiv Askvig, a board member and
primary insider in Ultimovacs ASA, has today sold 140,000 shares in the company
at an average price of NOK 7.2507 per share. Following these transactions,
Helene Sundt AS holds 0 shares in Ultimovacs ASA.
Sundt AS, a closely related party of Leiv Askvig, a board member and primary
insider in Ultimovacs ASA, has today sold 140,000 shares in the company at an
average price of NOK 7.2507 per share. Following these transactions, Sundt AS
holds 0 shares in Ultimovacs ASA.
This information is subject to the disclosure requirements pursuant to the
Market Abuse Regulation article 19 and section 5-12 of the Norwegian Securities
Trading Act.